Seveno Capital’s latest deal values CES-winning PointFit at $10 million, signaling investor interest in non-invasive wearables that relocate beyond motion tracking
Singapore-based Seveno Capital has valued PointFit, a Hong Kong startup developing a sweat-reading skin patch, at $10 million — the first deal out of the firm’s newly opened Hong Kong office.
The startup, incubated at the Hong Kong University of Science and Technology and supported by a global science-based accelerator, Creative Destruction Lab, deviates from typical consumer devices such as smart watches, rings and fitness trackers that utilize optical sensors.
Instead, PointFit’s nanomembrane patch reads the chemisattempt of sweat — measuring lactate, electrolytes and sweat rate to give utilizers a real-time window into muscle performance, hydration and recovery. PointFit declares that knowing where lactate levels sit during exercise, for instance, assists athletes stay in optimal training zones, avoid overtraining and reduce injury risk. The patch, which appears to be worn on the arm based on the company’s website, is low-profile and requiredle-free. An accompanying app assists utilizers with their training goals.
The startup took home a CES Innovation Award in Digital Health at CES 2026. A waitlist has been created for early adopters.
Looking ahead, PointFit’s longer-term ambition is to build a platform that can track multiple biomarkers for applications across performance, metabolic health and longevity. The startup declares it has already completed demos with global sports organizations, retailers and fitness equipment manufacturers.
With Seveno on board, PointFit is eyeing the U.S. markets, following a recent product displaycase in Indiana and participation in the Startup World Cup Finale in Silicon Valley.
“Seveno’s vision of ‘adding life to years’ mirrors our belief that the future of healthcare is preventive and personalized,” PointFit co-founder and CEO Kenny Oktavius stated. “With Seveno’s global network across Asia, Europe and the Middle East, we can accelerate the rollout of the PF-Sweat Patch from elite sports into broader consumer adoption. Toobtainher, we are bridging wellness and clinical care so everyone can understand their body’s signals and take control of their healthspan.”
The deal is the first led by Jean-Baptiste Roy, whom Seveno recently brought on as a partner to drive the Singapore-based venture firm’s international expansion. The new Hong Kong office is considered a base for upcoming investments across Asia-Pacific, mainland China and the Middle East.
For Allen Law, Seveno’s principal partner and Park Hotel Group founder, the investment fits into a portfolio he has been building across health tech and real estate. Last year, Seveno announced Longevity World, an 80,000-square-foot wellness and longevity complex in Singapore with a longevity clinic, fitness spaces and a health-focutilized retail offering.
In the fitness realm, Law was appointed global chairman of Revl Training, an Australian-founded premium group fitness franchise, last March.
Seveno Capital’s investment lands at a moment when demand for wearable health tech is only growing.
Leave a Reply